Lung cancer, Non small cell lung cancer (NSCLC)
Results
Phase 3
This trial compared erlotinib to a dummy drug () after surgery for non small cell lung cancer (NSCLC).
The trial was open for people to join between 2007 and 2010. The team published the results in 2015. There is a link to more information in the ‘Summary of results’ section below.
Recruitment start: 1 November 2007
Recruitment end: 31 July 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Clive Mulatero
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
OSI Pharmaceuticals
Last reviewed: 15 November 2023
CRUK internal database number: 2710
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
